Skip to content
Screener

Total Revenue at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$12.97B+5.7%
Pfizer logo
PfizerPFE
$15.03B+2.6%
Merck & Co. logo
Merck & Co.MRK
$16.61B+5.1%
Nuvation Bio logo
Nuvation BioNUVB
$31.69M+556%

Other financials

Income statement

See full
Operating income-$14.1M-146%
Net income-$14.2M-151%
EPS (diluted)-$0.58-93.3%

Balance sheet

See full
Cash & equivalents$2.0M+1,478%
Total debt$648.2K+63.9%
Total equity-$18.5M-56.8%
Total assets$5.2M+75.1%

Cash flow

See full
Operating cash flow-$4.8M+10.3%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$86.13M-57.9%
Enterprise value$84.8M-58.6%
P/S1,435.7×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%

Returns & leverage

See full
Return on equity311.1%
Debt / equity-0×
Current ratio0.2×+0.1×

Where this comes from

Reported directly by Neonc Technologies Holdings in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Neonc Technologies Holdings’s 10-Q, filed August 10, 2026. Open the filing →

Filed
Aug 10, 2026, 9:00 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001829126-26-008512

FAQ

What is Neonc Technologies Holdings's total revenue?
Neonc Technologies Holdings (NTHI) reported total revenue of $0 in Q2 2026.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Neonc Technologies Holdings's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude